Literature DB >> 21756177

Adrenalectomy in dogs with adrenal gland tumors: 52 cases (2002-2008).

Federico Massari1, Stefano Nicoli, Giorgio Romanelli, Paolo Buracco, Eric Zini.   

Abstract

OBJECTIVE: To evaluate predictors of survival time in dogs undergoing adrenalectomy and identify risk factors associated with adrenal gland tumor metastasis and vein thrombosis.
DESIGN: Retrospective case series. ANIMALS: 52 dogs with primary adrenal gland tumors. PROCEDURES: Medical records were reviewed. Signalment, tumor features, and information from surgical procedures were evaluated to identify factors predictive of overall survival time, which was defined as the time from surgery until death. The association between metastasis or vein thrombosis and tumor type, size, and site (right or left adrenal gland) was investigated.
RESULTS: On the basis of results of univariate analysis, survival time was significantly shorter for dogs with adenocarcinoma, tumor major axis length ≥ 5 cm, metastasis, and vein thrombosis and when adrenalectomy was combined with an additional abdominal surgical intervention. On multivariate analysis, survival time was significantly shorter for dogs with an adrenal gland tumor with major axis length ≥ 5 cm and for dogs with metastasis or vein thrombosis. Significant associations were found between metastasis and adenocarcinoma and between vein thrombosis and tumors with major axis length ≥ 5 cm. CONCLUSIONS AND CLINICAL RELEVANCE: Dogs with an adrenal gland tumor with major axis length ≥ 5 cm, documented metastasis, or vein thrombosis had a poorer prognosis. Metastasis was more frequent in dogs with adenocarcinoma and vein thrombosis when tumors were ≥ 5 cm in length.

Entities:  

Mesh:

Year:  2011        PMID: 21756177     DOI: 10.2460/javma.239.2.216

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  19 in total

1.  The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours.

Authors:  Karin Sanders; Koen Cirkel; Guy C M Grinwis; Erik Teske; Sebastiaan A van Nimwegen; Jan A Mol; Jan Willem Hesselink; Hans S Kooistra; Sara Galac
Journal:  Vet Comp Oncol       Date:  2019-04-07       Impact factor: 2.613

2.  C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.

Authors:  Kayla Harding; Carlos H De Mello Souza; Keijiro Shiomitsu; Elizabeth Maxwell; Judit Bertran
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

3.  Ultrasonographic features of adrenal gland lesions in dogs can aid in diagnosis.

Authors:  Elena Pagani; Massimiliano Tursi; Chiara Lorenzi; Alberto Tarducci; Barbara Bruno; Enrico Corrado Borgogno Mondino; Renato Zanatta
Journal:  BMC Vet Res       Date:  2016-11-28       Impact factor: 2.741

4.  Adrenocortical tumor in a cat secreting more than one type of corticosteroid.

Authors:  Simone Domit Guerios; Carlos Henrique de Melo Souza; Nicholas J Bacon
Journal:  JFMS Open Rep       Date:  2015-12-01

Review 5.  Volumetric Modulated Arc (Radio) Therapy in Pets Treatment: The "La Cittadina Fondazione" Experience.

Authors:  Mario Dolera; Luca Malfassi; Nancy Carrara; Sara Finesso; Silvia Marcarini; Giovanni Mazza; Simone Pavesi; Massimo Sala; Gaetano Urso
Journal:  Cancers (Basel)       Date:  2018-01-24       Impact factor: 6.639

6.  Anaesthetic management of a unilateral adrenalectomy of an adrenocortical tumour in a dog.

Authors:  I K Wise; S Boveri
Journal:  Open Vet J       Date:  2016-04-07

7.  Treatment of aldosterone-secreting adrenocortical tumors in cats by unilateral adrenalectomy: 10 cases (2002-2012).

Authors:  A J Lo; D E Holt; D C Brown; M D Schlicksup; R J Orsher; K A Agnello
Journal:  J Vet Intern Med       Date:  2013-12-26       Impact factor: 3.333

8.  Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.

Authors:  C Arenas; C Melián; M D Pérez-Alenza
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

9.  Repetitive ultrasonographic assessment of adrenal size and shape changes: a clue for an asymptomatic sex hormone-secreting adenoma.

Authors:  Seunghyeon Yoon; Heejin Oui; Ju-Hwan Lee; Kyu-Yeol Son; Kyoung-Oh Cho; Jihye Choi
Journal:  J Vet Sci       Date:  2017-03-30       Impact factor: 1.672

10.  ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.

Authors:  Daniel K Langlois; Michele C Fritz; William D Schall; N Bari Olivier; Rebecca C Smedley; Paul G Pearson; Marc B Bailie; Stephen W Hunt
Journal:  BMC Endocr Disord       Date:  2018-05-02       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.